CNADF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Apr 10 closing price
Capitalization
4.5M
STEK
Price
$0.02
Change
-$0.00 (-0.00%)
Updated
Aug 28 closing price
Capitalization
2.41M
Interact to see
Advertisement

CNADF vs STEK

Header iconCNADF vs STEK Comparison
Open Charts CNADF vs STEKBanner chart's image
CANADABIS CAP
Price$0.06
Change-$0.00 (-0.00%)
Volume$6K
Capitalization4.5M
Stemtech
Price$0.02
Change-$0.00 (-0.00%)
Volume$620.3K
Capitalization2.41M
CNADF vs STEK Comparison Chart in %
Loading...
STEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNADF vs. STEK commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNADF is a Hold and STEK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (CNADF: $0.06 vs. STEK: $0.02)
Brand notoriety: CNADF and STEK are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CNADF: 100% vs. STEK: 468%
Market capitalization -- CNADF: $4.5M vs. STEK: $2.41M
CNADF [@Pharmaceuticals: Generic] is valued at $4.5M. STEK’s [@Pharmaceuticals: Generic] market capitalization is $2.41M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNADF’s FA Score shows that 0 FA rating(s) are green whileSTEK’s FA Score has 0 green FA rating(s).

  • CNADF’s FA Score: 0 green, 5 red.
  • STEK’s FA Score: 0 green, 5 red.
According to our system of comparison, CNADF is a better buy in the long-term than STEK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STEK’s TA Score shows that 4 TA indicator(s) are bullish.

  • STEK’s TA Score: 4 bullish, 4 bearish.

Price Growth

CNADF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while STEK (@Pharmaceuticals: Generic) price change was -31.25% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.25%. For the same industry, the average monthly price growth was +68.20%, and the average quarterly price growth was +81.63%.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNADF($4.5M) has a higher market cap than STEK($2.41M). CNADF YTD gains are higher at: 78.571 vs. STEK (-64.363). CNADF has higher annual earnings (EBITDA): 1.54M vs. STEK (-3.06M). CNADF has more cash in the bank: 948K vs. STEK (260K). STEK has less debt than CNADF: STEK (4.07M) vs CNADF (9.18M). CNADF has higher revenues than STEK: CNADF (17.2M) vs STEK (5.1M).
CNADFSTEKCNADF / STEK
Capitalization4.5M2.41M186%
EBITDA1.54M-3.06M-50%
Gain YTD78.571-64.363-122%
P/E Ratio11.57N/A-
Revenue17.2M5.1M337%
Total Cash948K260K365%
Total Debt9.18M4.07M226%
FUNDAMENTALS RATINGS
STEK: Fundamental Ratings
STEK
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNADFSTEK
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
30%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
35%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
STEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NCTY9.340.69
+7.98%
The9 Limited
CRDO131.829.09
+7.41%
Credo Technology Group Holding Ltd
ABL6.930.02
+0.29%
Abacus Global Management Inc
GENI12.830.01
+0.08%
Genius Sports Limited
YAAS0.32-0.01
-3.17%
Youxin Technology Ltd

CNADF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNADF has been loosely correlated with BJTRF. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CNADF jumps, then BJTRF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNADF
1D Price
Change %
CNADF100%
N/A
BJTRF - CNADF
61%
Loosely correlated
N/A
STEK - CNADF
26%
Poorly correlated
-4.07%
PLSH - CNADF
21%
Poorly correlated
N/A
HLN - CNADF
15%
Poorly correlated
-0.21%
PLNH - CNADF
5%
Poorly correlated
-2.41%
More

STEK and

Correlation & Price change

A.I.dvisor tells us that STEK and CNADF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that STEK and CNADF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STEK
1D Price
Change %
STEK100%
-4.07%
CNADF - STEK
25%
Poorly correlated
N/A
BFRI - STEK
12%
Poorly correlated
-0.99%
HLNCF - STEK
11%
Poorly correlated
+0.10%
PLSH - STEK
8%
Poorly correlated
N/A
EAPIF - STEK
6%
Poorly correlated
N/A
More